Protective effect of glucagon‐like peptide‐2 in experimental corrosive esophagitis

E-ISSN： 1442-2050|28|3|258-261

ISSN： 1120-8694

Source： DISEASES OF THE ESOPHAGUS (ELECTRONIC), Vol.28, Iss.3, 2015-04, pp. : 258-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat models

International Journal of Molecular Medicine, Vol. 31, Iss. 3, 2013-01 ,pp. : 607-613

Spandidos Publications

Access to resources Recommend Favorite

Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes

By Ross Stuart A. Ballantine Jane

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1617-1626

Informa Healthcare

Access to resources Recommend Favorite

Increased Postprandial Response of Glucagon-Like Peptide-2 in Patients with Chronic Pancreatitis and Pancreatic Exocrine Insufficiency

Pancreatology, Vol. 10, Iss. 2-3, 2010-05 ,pp. : 201-207

Karger

Access to resources Recommend Favorite

Glucagon‐like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 335-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lack of effect of the glucagon‐like peptide‐1 receptor agonist liraglutide on psoriasis in glucose‐tolerant patients – a randomized placebo‐controlled trial

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 555-559

John Wiley & Sons Inc

Access to resources Recommend Favorite